骨肌的消耗性缩:通过omega-3多不和脂肪酸进行保护
Oleksandr Obrosov1, Lawrence J Coppey1, Eric P Davidson1
1Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, United States of America.
NFS journal
|December 31, 2025
概括
欧米茄-3脂肪酸及其代谢物溶D1可以防止骨肌肉的消耗和缩. 在固定化之前或期间通过饮食或注射补充剂显示出显著的保护性益处.
科学领域:
- 生物化学 生物化学
- 肌肉生理学 肌肉生理学
- 营养科学 营养科学
背景情况:
- 骨肌的失效缩是一个重要的临床问题.
- 欧米茄-3多不和脂肪酸 (PUFA) 和它们的代谢物以抗炎性质而闻名.
- 研究它们在预防肌肉损失中的作用至关重要.
研究的目的:
- 调查omega-3PUFA (鱼油) 和resolvin D1对骨肌肉不使用缩的保护作用.
- 为了比较食补充剂与直接服用resolvin的疗效 D1.1.
主要方法:
- 在一周内诱导C57Bl6/J雄性小鼠的前肌的失效缩.
- 治疗组接受了富含孟哈登油的饮食或每天注射RESOLVIN D1.
- 干预时间包括预治疗和与固定固定并发的治疗.
- 肌肉缩通过比较四肢重量和通过免疫组织化学评估.
主要成果:
- 一个为期2周的预防方案,使用富含孟哈登油的饮食或resolvin D1注射提供了对肌肉缩的最显著的保护.
- 在固定时开始的饮食干预也显示出显著的保护作用.
- 欧米茄-3 PUFA 和resolvin D1 均在减轻肌肉损失方面表现出有效性.
结论:
- 欧米茄-3 PUFA 和它们的代谢物溶解D1 能够有效地预防骨肌肉的消耗缩.
- 早期干预omega-3脂肪酸,通过饮食或resolvin D1的管理,有利于预防肌肉缩.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


